BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+13.6%
5Y CAGR+7.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+13.6%/yr
vs +12.4%/yr prior
5Y CAGR
+7.0%/yr
Recent acceleration
Acceleration
+1.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $736.83M | +27.0% |
| 2024 | $580.24M | +9.1% |
| 2023 | $532.06M | +5.8% |
| 2022 | $503.02M | +6.9% |
| 2021 | $470.51M | -10.3% |
| 2020 | $524.27M | +45.8% |
| 2019 | $359.47M | +14.0% |
| 2018 | $315.26M | +30.4% |
| 2017 | $241.79M | +15.3% |
| 2016 | $209.62M | - |